These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 8963976
1. Intravesical oxybutynin for spinal cord injury patients. Szollar SM, Lee SM. Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976 [Abstract] [Full Text] [Related]
2. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction. Vaidyananthan S, Soni BM, Brown E, Sett P, Krishnan KR, Bingley J, Markey S. Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197 [Abstract] [Full Text] [Related]
3. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder. Kaplinsky R, Greenfield S, Wan J, Fera M. J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776 [Abstract] [Full Text] [Related]
4. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Pannek J, Sommerfeld HJ, Bötel U, Senge T. Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610 [Abstract] [Full Text] [Related]
5. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children. Amark P, Bussman G, Eksborg S. Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251 [Abstract] [Full Text] [Related]
6. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder. Mizunaga M, Miyata M, Kaneko S, Yachiku S, Chiba K. Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832 [Abstract] [Full Text] [Related]
7. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters. Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, van Gool JD. Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114 [Abstract] [Full Text] [Related]
8. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization]. Yokoyama O, Ishiura Y, Nakamura Y, Ohkawa M. Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182 [Abstract] [Full Text] [Related]
9. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127 [Abstract] [Full Text] [Related]
10. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Haferkamp A, Staehler G, Gerner HJ, Dörsam J. Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396 [Abstract] [Full Text] [Related]
11. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury. George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S. ScientificWorldJournal; 2007 Oct 22; 7():1683-90. PubMed ID: 17982563 [Abstract] [Full Text] [Related]
12. The use of intravesical oxybutynin chloride in children with neurogenic bladder. Greenfield SP, Fera M. J Urol; 1991 Aug 22; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294 [Abstract] [Full Text] [Related]
13. The role of oxybutynin in spinal cord injured patients with indwelling catheters. Kim YH, Bird ET, Priebe M, Boone TB. J Urol; 1997 Dec 22; 158(6):2083-6. PubMed ID: 9366317 [Abstract] [Full Text] [Related]
14. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E. BJU Int; 2001 May 22; 87(7):674-8. PubMed ID: 11350411 [Abstract] [Full Text] [Related]
15. Intravesical therapy for the treatment of neurogenic bladder in children. Holland AJ, King PA, Chauvel PJ, O'Neill MK, McKnight DL, Barker AP. Aust N Z J Surg; 1997 Oct 22; 67(10):731-3. PubMed ID: 9322726 [Abstract] [Full Text] [Related]
16. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB. J Urol; 1994 Apr 22; 151(4):944-5. PubMed ID: 8126833 [Abstract] [Full Text] [Related]
17. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. Am J Dis Child; 1992 Jul 22; 146(7):840-3. PubMed ID: 1496955 [Abstract] [Full Text] [Related]
18. Can Oral Fesoterodine Be an Alternative for Intravesical Oxybutynin Instillations in Children with Neuropathic Bladder Dysfunction? van den Heijkant M, De Coster K, Jansen K, Bogaert G. Urol Int; 2019 Jul 22; 103(2):202-210. PubMed ID: 31117096 [Abstract] [Full Text] [Related]
19. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity. Prasad KV, Vaidyanathan S. Br J Urol; 1993 Nov 22; 72(5 Pt 2):719-22. PubMed ID: 8281402 [Abstract] [Full Text] [Related]
20. [Intravesical oxybutynin treatment for neurogenic detrusor overactivity : Efficacy and safety data from clinical practice with the first intravesical oxybutynin treatment authorized in Germany]. Schindler O, Ho H, Leidl Q, Angermund A, Elishar R, Frech-Dörfler M, Hirsch A, Kalke YB, Kirschner-Herrmanns R, Tornic J, Queissert F, Rahnama'i S, Rehme C, Reitz A, Schmitz F, Schultz-Lampel D, Gedamke M. Urologie; 2024 Jul 22; 63(7):693-701. PubMed ID: 38755461 [Abstract] [Full Text] [Related] Page: [Next] [New Search]